Becton, Dickinson and Co. | BDX - Ebit

Stock Price
191.58
Daily Change
-0.81 -0.42%
Monthly
-0.48%
Yearly
-19.21%
Q3 Forecast
190.79

Becton, Dickinson and Co. reported $979M in EBIT for its fiscal quarter ending in June of 2025.




Ebit Change Date
Abbott USD 2.07B 105M Jun/2025
Agilent USD 394M 31M Jul/2025
Align Technology USD 163.03M 23.69M Jun/2025
Avanos Medical USD -53660000 65.46M Jun/2025
Baxter International USD 272M 120M Jun/2025
Becton, Dickinson and Co. USD 979M 379M Jun/2025
Bio-Rad Laboratories USD 426.6M 363.6M Jun/2025
Boston Scientific USD 942M 408M Jun/2025
Cooper Companies USD 177.3M 72.2M Jul/2025
Danaher USD 760M 939M Jun/2025
Dentsply International USD 111M 23M Jun/2025
Dexcom USD 245.8M 102.7M Jun/2025
Edwards Lifesciences USD 430.9M 19.6M Jun/2025
Exact Sciences USD -2148000 93.86M Jun/2025
Globus Medical USD -125953000 224.01M Jun/2025
Hologic USD 263.9M 37.7M Jun/2025
Insulet USD 121.1M 32.3M Jun/2025
Integra LifeSciences USD -509910000 498.69M Jun/2025
Intuitive Surgical USD 746.9M 20.6M Jun/2025
J&J USD 6.94B 443M Jun/2025
Masimo USD 64.5M 42.4M Jun/2025
Medtronic USD 1.52B 969M Jul/2025
Solventum Corp USD 214M 193M Jun/2025
Stryker USD 1.17B 176M Jun/2025
Tandem Diabetes Care USD -31859000 2.64M Jun/2025
Teleflex USD 156.95M 29.47M Jun/2025
Terumo JPY 55.89B 20.31B Jun/2025
Thermo Fisher Scientific USD 1.92B 353M Jun/2025
Zimmer Biomet Holdings USD 396.4M 101.2M Jun/2025